Macter produces specialty products at its state-of-the-art plants. These include solid and liquid oral dosage forms (tablets, capsules, syrups, suspensions, and dry powders), injections (sterile liquid vials, sterile liquid ampoules, and sterile dry powders), ointments and creams, drops, and inhalers.
Macter International has a state-of-the-art Tablet Manufacturing facility. In this facility, a team of pharmacists, chemists, and engineers produces high-quality branded tablet products. Our facility is trusted by leading pharmaceutical companies worldwide for the production of premium tablets.
Macter has a dedicated capsule production facility for PENICILLIN, CEPHALOSPORIN, and non-antibiotic products. State-of-the-art, CFR-compliant equipment ensures the production of high-quality capsule products for Macter’s own brands, leading multinational and local companies, as well as the international market.
At Macter International, a team of qualified staff, including pharmacists, microbiologists, and engineers, work diligently to maintain a state-of-the-art Injectable Manufacturing facility. The facility is fully capable of producing injectable products that comply with both local and international standards, which has helped Macter establish a strong presence abroad for its high-quality injectables.
Using a high-tech Italian filling and packaging facility, Macter produces branded creams and ointments for leading multinational and local clients. This facility ensures that all products meet stringent quality standards.
Macter maintains a dedicated high-tech powder filling facility for the production of dry powders. PENICILLIN and CEPHALOSPORIN are produced to the highest standards, serving both leading international pharmaceutical giants and Macter’s own brands.
Macter’s broad range of dosage forms also includes syrups and liquid formulations. This facility is one of the largest in terms of bulk production and service capability, supporting both leading multinational and local clients. It reflects Macter’s expertise and capacity in producing high-quality liquid products.
Dedicated Facilities
Penicillin (antibiotic)
Aerosol area
Biotech
Macter is a pioneering company in Pakistan, having established a state-of-the-art manufacturing plant for biotech drugs.
Manufacturing operations include formulation, vial filling, lyophilization, and packaging of biological drugs, with a capacity of 16 million vials per annum for liquid formulations and 4 million vials per annum for lyophilized products.
This facility can efficiently meet the national demand for life-saving biological drugs.
Macter uses state-of-the-art technological facilities, stringent quality and safety standards, environmentally friendly processes, and highly efficient operating procedures, supported by a technically proficient and motivated team.
Macter produces specialty products at its high-tech plant, including:
Solid and liquid oral dosage forms: tablets, capsules, syrups, suspensions, and dry powders
Injections: sterile liquid vials, sterile liquid ampoules, and sterile dry powders
Topical formulations: ointments and creams
Others: drops and inhalers
Our operations are supported by a highly qualified and trained team of scientists, pharmacists, and chemists, assisted by skilled engineers and technicians, working in an environment that promotes continuous improvement and operational excellence.